These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Discovery of 3-arylpropionic acids as potent agonists of sphingosine-1-phosphate receptor-1 (S1P1) with high selectivity against all other known S1P receptor subtypes. Yan L; Huo P; Doherty G; Toth L; Hale JJ; Mills SG; Hajdu R; Keohane CA; Rosenbach MJ; Milligan JA; Shei GJ; Chrebet G; Bergstrom J; Card D; Quackenbush E; Wickham A; Mandala SM Bioorg Med Chem Lett; 2006 Jul; 16(14):3679-83. PubMed ID: 16697189 [TBL] [Abstract][Full Text] [Related]
12. Synthesis and SAR studies of benzyl ether derivatives as potent orally active S1P₁ agonists. Tsuji T; Suzuki K; Nakamura T; Goto T; Sekiguchi Y; Ikeda T; Fukuda T; Takemoto T; Mizuno Y; Kimura T; Kawase Y; Nara F; Kagari T; Shimozato T; Yahara C; Inaba S; Honda T; Izumi T; Tamura M; Nishi T Bioorg Med Chem; 2014 Aug; 22(15):4246-56. PubMed ID: 24909680 [TBL] [Abstract][Full Text] [Related]
13. Synthesis and SAR of 1,3-thiazolyl thiophene and pyridine derivatives as potent, orally active and S1P₃-sparing S1P₁ agonists. Asano M; Nakamura T; Sekiguchi Y; Mizuno Y; Yamaguchi T; Tamaki K; Shimozato T; Doi-Komuro H; Kagari T; Tomisato W; Inoue R; Yuita H; Oguchi-Oshima K; Kaneko R; Nara F; Kawase Y; Masubuchi N; Nakayama S; Koga T; Namba E; Nasu H; Nishi T Bioorg Med Chem Lett; 2012 May; 22(9):3083-8. PubMed ID: 22487179 [TBL] [Abstract][Full Text] [Related]
15. Discovery of a brain-penetrant S1P₃-sparing direct agonist of the S1P₁ and S1P₅ receptors efficacious at low oral dose. Demont EH; Arpino S; Bit RA; Campbell CA; Deeks N; Desai S; Dowell SJ; Gaskin P; Gray JR; Harrison LA; Haynes A; Heightman TD; Holmes DS; Humphreys PG; Kumar U; Morse MA; Osborne GJ; Panchal T; Philpott KL; Taylor S; Watson R; Willis R; Witherington J J Med Chem; 2011 Oct; 54(19):6724-33. PubMed ID: 21838322 [TBL] [Abstract][Full Text] [Related]
16. 2-Aryl(pyrrolidin-4-yl)acetic acids are potent agonists of sphingosine-1-phosphate (S1P) receptors. Yan L; Budhu R; Huo P; Lynch CL; Hale JJ; Mills SG; Hajdu R; Keohane CA; Rosenbach MJ; Milligan JA; Shei GJ; Chrebet G; Bergstrom J; Card D; Mandala SM Bioorg Med Chem Lett; 2006 Jul; 16(13):3564-8. PubMed ID: 16621543 [TBL] [Abstract][Full Text] [Related]
17. Identification of Leu276 of the S1P1 receptor and Phe263 of the S1P3 receptor in interaction with receptor specific agonists by molecular modeling, site-directed mutagenesis, and affinity studies. Deng Q; Clemas JA; Chrebet G; Fischer P; Hale JJ; Li Z; Mills SG; Bergstrom J; Mandala S; Mosley R; Parent SA Mol Pharmacol; 2007 Mar; 71(3):724-35. PubMed ID: 17170199 [TBL] [Abstract][Full Text] [Related]
18. 2,5-Disubstituted pyrrolidine carboxylates as potent, orally active sphingosine-1-phosphate (S1P) receptor agonists. Colandrea VJ; Legiec IE; Huo P; Yan L; Hale JJ; Mills SG; Bergstrom J; Card D; Chebret G; Hajdu R; Keohane CA; Milligan JA; Rosenbach MJ; Shei GJ; Mandala SM Bioorg Med Chem Lett; 2006 Jun; 16(11):2905-8. PubMed ID: 16580205 [TBL] [Abstract][Full Text] [Related]
19. Novel 5- and 6-subtituted benzothiazoles with improved physicochemical properties: potent S1P₁ agonists with in vivo lymphocyte-depleting activity. Frohn M; Cee VJ; Lanman BA; Pickrell AJ; Golden J; Rivenzon-Segal D; Middleton S; Fiorino M; Xu H; Schrag M; Xu Y; McElvain M; Muller K; Siu J; Bürli R Bioorg Med Chem Lett; 2012 Jan; 22(1):628-33. PubMed ID: 22100314 [TBL] [Abstract][Full Text] [Related]
20. Optimization of sphingosine-1-phosphate-1 receptor agonists: effects of acidic, basic, and zwitterionic chemotypes on pharmacokinetic and pharmacodynamic profiles. Skidmore J; Heer J; Johnson CN; Norton D; Redshaw S; Sweeting J; Hurst D; Cridland A; Vesey D; Wall I; Ahmed M; Rivers D; Myatt J; Giblin G; Philpott K; Kumar U; Stevens A; Bit RA; Haynes A; Taylor S; Watson R; Witherington J; Demont E; Heightman TD J Med Chem; 2014 Dec; 57(24):10424-42. PubMed ID: 25431977 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]